Loading provider…
Loading provider…
Interventional Cardiology Physician in Weston, FL
NPI: 1386717114Primary Practice Location
CLEVELAND CLINIC HOSPITAL
2950 Cleveland Clinic Blvd, Weston, FL
Primary Employer
Cleveland Clinic Florida a Nonprofit Corporation
my.clevelandclinic.org
HQ Phone
Get MD Mauricio's Phone Numberphone_androidMobile
Get MD Mauricio's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
FL State Medical License
FL State Medical License
2008 - 2027
NC State Medical License
2004 - 2026
Duke University Hospital
Fellowship • Interventional Cardiology
1997 - 1999
Hospital Italiano de Buenos Aires
1992 - 1997
1992 - 1997
National University of Tucuman Faculty of Medicine
Medical School
Until 1991
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 82 | 101 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 55 | 55 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 47 | 47 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 35 | 39 |
| 5 | 33361Replacement of aortic valve through the skin and femoral artery | 30 | 30 |
Reversal of end stage renal disease in patient with transcatheter aortic valve replacement.
Authors: Abdulla Damluji, Martin Bilsker
Publication Date: 2013-08-08
Synergistic action of severe wall injury and shear forces on thrombus formation in arterial stenosis: definition of a thrombotic shear rate threshold.
Authors: Merino A, Cohen M, Badimon JJ, Fuster V, Badimon L
Publication Date: 1994-10
To revascularize or not before transcatheter aortic valve implantation?
Authors: Sergio Perez, Torin Thielhelm, Mauricio Cohen
Publication Date: 2018-12-04
Lead Sponsor: Joshua M Hare
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Intervention / Treatment: OTHER: Placebo, DRUG: 100 million Allogeneic Mesenchymal Human Stem Cells
Lead Sponsor: Abbott Medical Devices
Intervention / Treatment: DEVICE: Any Abiomed Impella® device approved for use in high-risk PCI, DEVICE: HeartMate PHP
Lead Sponsor: Regado Biosciences, Inc.
Collaborators: The Cleveland Clinic, Duke Clinical Research Institute, Icahn School of Medicine at Mount Sinai, Parexel, Canadian VIGOUR Centre
Intervention / Treatment: DRUG: Bivalirudin, DRUG: pegnivacogin/anivamersen